Abstract Small bowel transplantation (SBT) would, in theory, be the treatment of choice for patients suffering from the short bowel syndrome. Although SBT has been done with a considerable degree of success in some centers [36,145], it is by no means an established or widely applicable therapy for those with short bowel syndrome. The small bowel is unique among vascularized organ grafts because it not only elicits a vigorous rejection reaction but is also capable of inducing graft-versus-host disease (GVHD). Rejection of the graft does not only lead to loss of function but also to bacterial translocation. The risk of fatal sepsis is aggravated by the immunosuppression given to prevent rejection. Here, the history of SBT is described, and recent developments in experimental and clinical SBT, as well as future prospects for this theoretically optimal treatment modality for patients dependent on total parenteral nutrition (TPN) for life, are outlined.
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History
In 1959, Lillehei et al. [73] described, for the first time, a technique for orthotopic small bowel transplantation (SBT) in the dog. Many experimental studies followed and several patients received a small bowel transplant. However, the initial enthusiasm for SBT waned when it became evident that rejection and sepsis were recurrent problems that could not easily be solved and when total parenteral nutrition (TPN) was introduced as satisfactory therapy for otherwise untreatable patients. With the introduction of the potent immunosuppressive agent cyclosporin A (CyA) came a renewed interest in SBT, which is presently on the verge of becoming an established procedure in transplant medicine.
Experimental models of small bowel transplantation
A number of models are used to study SBT, each having its own advantages and disadvantages. Monchik and Russell [90] first used parent and F1 hybrid rats in SBT. By using rats from two inbred parent (P) strains and their offspring (F1), they were able to distinguish graft-versus-host disease (GVHD) from rejection. Transplantation from P to F1 produces only GVHD, whereas in the reverse siutation only rejection occurs. The relevance of these one-way semiallogeneic models to the clinical situation, in which both GVHD and rejection may occur, is uncertain [114] and, hence, fully allogeneic combinations, in which the graft is transplanted from P1 to P2, are used to study the possible interaction between GVHD and rejection. Syngeneic transplantation from P1 to P1 can be used to study the effects of ischemia and lymphatic and neural disruption while the immunologically induced traumas are circumvented (Table 1) . In large animals, syngeneic transplantation finds its equal in autotransplantation, in which the arterial and venous blood supply are divided and reanastomosed, the lymphatics and nerves are disrupted, and the bowelis cut and reanastomosed [73, 84, 107] .
With respect to the position of the bowel, two models are used. In one, the bowel is placed heterotopically; the recipient small bowel remains in situ, and the graft is placed as a Thiry-Vella fistula with both ends of the graft anasto- Table I Immunological reac-Model GVHD Rejection tions after smalt bowel transplantation P1 --~ P1 --F1 ---~P -+ P--~F1 + P1 ---~ P2 + + mosed as stomas in the abdominal wall of the recipient. The oral end of the graft may also be ligated or placed as a duodenostoma, whereas the distal end is anastomosed end-to-side to the terminal ileum of the recipient bowel. In the orthotopic model, the recipient small bowel is resected and the graft is placed in continuity with the remaining duodenum and terminal ileum of the recipient. In this model, recipient survival is dependent upon the functioning of the graft. Although orthotopic SBT (OSBT) may be the preferred model [38, 68] , the reported longer operative time and higher incidence of complications [62, 63] have resulted in a number of studies in which heterotopic SBT (HSBT) has been used [150] . In skilled hands, however, the operative time and technical success rate for both techniques are not significantly different [159] . Results obtained after HSBT and OSBT are not comparable [38, 68] . After HSBT, rejection of the graft is defined as the development of a palpable abdominal mass and necrosis of stomas [38, 68] . However, the graft may become encapsulated and fibrotic rather than necrotic and perforated, and the recipient may survive despite the graft loss, which makes the end point of rejection more difficult to define [38, 123] . Moreover, probably due to a lack of intraluminal nutrients, atrophy of the mucosa occurs [151] , and the permeability of these grafts 7 days postoperatively is significantly higher than after OSBT. Graft survival after HSBT can be prolonged more easily than after OSBT [38] . In conclusion, OSBT may be the preferred model for both immunological and functional studies.
Venous drainage of the graft may be in the portal or in the systemic circulation. Although technically more demanding [131], portoportal drainage is the more physiological route. Beneficial effects of this route on graft survival have been reported [63, 123] , although they may be of minor importance [69] . Portocaval shunting may cause metabolic complications, such as a rise in blood ammonia levels, and liver atrophy. The effects of portocaval shunting after SBT appear to be minor, and either type of venous drainage may be used safely [53, 63, 123, 131] . Lillehei et al. [73] were the first to describe a technique for functional bowel transplantation in the dog. After the bowel had been removed, it was autotransplanted and subsequently had good function. Different models of heterotopic and orthotopic placement of the bowel, with either systemic or portal venous drainage, are used as preclinical models for the immunological and functional studies. Since pigs are inexpensive, easily cared for, and gain weight rapidly, they are also used in SBT [35, 54, 106] .
Histology
The sequence of histological changes after SBT is well defined, although there may be slight differences, depending on the model studied [46, 76, 90, 120] .
In our BN-to-WAG fully allogeneic, orthotopic total SBT model, early intestinal lesions on days 4-6 post-transplantation were characterized by mild infiltration of the lamina propria and submucosa by mononuclear cells and ne utrophils and by mild multifocal death of crypt epithelial cells. The number of mononuclear cells increased to moderate over a period of a few days, while only a few neutrophils were seen after 6 days. Crypt cell death was also observed on days 7-12 post-transplantation, but it never be came a prominent feature. Fibrin thrombi in mucosal capillaries were observed with increasing frequency during the course of graft rejection. This was associated with extensive necrosis of the mucosa at 11 and 12 days after grafting. Widespread thrombosis, resulting in ischemia, is probably the principal cause of graft necrosis. Mononuclear cells accumulated around blood vessels in the mesentery. At 11-12 days post-transplantation, early changes in the arteries included endothelial hypertrophy, and this was followed by mild intimal proliferation and thrombosis.
The mesenteric lymph node became rapidly depleted of lymphocytes, which were replaced by large mononuclear cells, presumably macrophages, and increasing numbers of fibroblasts.
Immunohistochemical changes generally predate histological ones. In rats, a huge number of macrophages are seen infiltrating the submucosa, peaking on day 7. Increasing numbers of T cells are seen starting on day" 3 in the submucosa, whereas their numbers are increased in the crypts on days 5 and 7 [44] . In humans, increased number ofmacrophages and CD 4 + cells are found in the lamina propria, and crypts express HLA-DR antigens [49] . Others have found pericryptic infiltrates of CD 3 + cells and HLA-DR expression on crypt enterocytes 3-5 days before histological changes became apparent [6] Immunosuppression with cyclosporin Before CyA became available, other immunosuppressive agents were used in attempts to prolong small bowel allograft survival. Taylor et al. [141] used high doses of azathioprine in the artificial model of transplantation of a small segment of small bowel as a Thiry-Vella fistula in the neck of dogs. Only marginal prolongation of graft survival was found. Preston et al. [104] , using the same model, added prednisone to azathioprine and found prolongation of graft survival from 9 to 27.5 days. Addition of antilymphocyte serum (ALS) to this regimen prolonged graft survival to a mean of 38 days [41] .
Interest in SBT has been rekindled since the introduction of the potent immunosuppressant CyA [57] . Reznick
